Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Azarga
Azarga is a fixed-dose combination medication containing brinzolamide, a carbonic anhydrase inhibitor, and timolol, a beta-blocker. It is used to lower intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Brinzolamide decreases aqueous humor production, while timolol reduces its formation. Azarga is typically prescribed when monotherapy with either drug is insufficient.
For lowering intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
Outcome:
Increased bradycardia and hypotension
Mechanism:
Additive beta-blocking effects
Outcome:
Reduced IOP-lowering effect
Mechanism:
NSAIDs can increase IOP
Outcome:
Potential additive or antagonistic effects on IOP
Mechanism:
Complex interactions on aqueous humor dynamics
Most likely new formulation: Sustained-release implant (2026, 60% confidence)
Based on current usage trends and clinical trial data, Azarga is expected to maintain its current market share for the next 5 years (80% confidence).
Antiglaucoma Agent
Sulfonamide, Beta-adrenergic blocking agent